Get started
EMVISION MEDICAL DEVICES LTDEMVISION MEDICAL DEVICES LTDEMVISION MEDICAL DEVICES LTD

EMVISION MEDICAL DEVICES LTD

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals

EMV trade ideas

EMV.ASX - Large Accending TriangleTo be honest this chart looks weak, but I've seen charts like this with this kind of setup pop, so I might put it on a watchlist. The large triangle has caputured the trade with the lower bound trendline being far steep than the upper. This sort of indicates that there is a good amount of demand underneath this stock, however since about the start of 2024 it really looks to be a bit weaker. This is indicated by most of the price action being close to the lower blue support level, and the price being sold down almost immediately once it hits the upper blue resistance level. The price action has to hold this 1.75 level otherwise it will likely drop sharply. We have very low volume being traded at the moment although the last few weeks there has been higher than average volume. This will hopefully keep the level. Before this chart can turn bullish it has to break 2.10, possibly reach 2.40, at which point it should retest 2.10. If the 2.10 level can be maintained on a retest then I would say that this chart is bullish and is worth a buy. Which would make for a good trade, as the first target is 3.20, and the stop is 1.75. Meaning a 15% risk for an initial 55% gain.
ASX:EMVLong
by MadButcherWA
EMV:ASX - EMVISION MEDICAL DEVICES - Monster run since March lowEMV is up over 800% since its March lows this year. EMVision is developing a portable brain scanner for rapid, point of care, stroke diagnosis and monitoring which sounds like a good space to be in. I have had an alert set at RSI(14) < 65 for a while now to try and get back into it at better value, but I'm sill waiting :) From their about us: EMVision Medical Devices Limited is focused on the development and commercialisation of medical imaging technology. The Company is developing and seeking to commercialise a potentially cost effective, portable, medical imaging device using electromagnetic microwave imaging for diagnosis and monitoring of stroke and other medical applications. The technology is the result of over 10 years of development by researchers at the University of Queensland. The team of approximately 30 researchers is led by co-inventors Professor Amin Abbosh, who is considered a global leader in electromagnetic microwave imaging, along with Professor Stuart Crozier, who created technology central to most MRI machines manufactured since 1997. EMVision’s CEO, Dr Ron Weinberger, is the Former Executive Director and CEO of Nanosonics' (ASX:NAN), a $1.65 billion market cap healthcare company. Dr Weinberger has over 25-years’ experience developing and commercialising medical devices. During his time at Nanosonics, Dr Weinberger codeveloped the company’s platform technology and launched their breakthrough product ‘Trophon’ globally, which would go on to become the gold standard for infection prevention. Dr Weinberger was instrumental in transforming Nanosonics from a research and development company to one of Australia’s leading medical device commercialisation success stories.
ASX:EMVLong
by zAngus
1
$EMV:ASX - EMVISION MEDICAL DEVICES - Awaiting announcementDespite no real news Emvision has been having a bit of a run of late and looks to have cleared a small resistance area. Good chance it is running on people anticipating that the trial mention in early September might be about to begin. See announcement "03/09/2019 8:28 am AEST On Target For Trial To Commence Q4 Calendar 2019 ". Worth a watch. Blame or praise to @StanH2443 on Twitter for pointing it out as it wasn't yet on my radar. EMvision Medical Devices Limited is an Australia-based medical device company. The Company is primarily focused on the development and commercialization of medical imaging technology. It is developing a medical imaging device using electromagnetic microwave imaging for diagnosis of brain stroke, and other organs and other medical applications.
ASX:EMVLong
by zAngus
Bullish Flag continuation pattern on $EMVEMV has seen continued absorption of shares following its recent rerate. With such a tight register and significant demand, coinciding with the resumption of the clinical trial, MRFF Stage 2 fund grant bids nearing completion (potential massive grant up for grabs that EMV has already successfully obtained stage 1) EMV is well poised to continue its upward trend. The chart is showing a bullish flag continuation pattern with an approximate target of $1.90.
ASX:EMVLong
by Sto
EMV solid downtrend reversal followed by significant demandEMV continues to demonstrate the lack of selling pressure post panic selling given macro global economic events. Hitting bottom of 40c some lucky punters picked a superb bottom and have since watched the price healthily appreciate through 2 continuation patterns. EMV's cash backing and potential for winning a undiluted funding through 2nd stage Medical Research Future Fund grant, de-risks the need for possible capital raising in the near term. The strong fundamentals in conjunction to the partially completed pilot clinical trials which are due to have their results released soon could have some serious blue sky positive movement in the near term. EMV has seen 3 notable (among many) positive indicators. a 12/20 SMA golden cross took place on the 6th of April which also saw a large uptick that broke through the 50% Fibonacci retracement , promptly followed by a 3 day consolidation before continuing into another more powerful golden cross ( 12/200sma ). Anyone watching the depth closely and the course of sales will note the way the buying has taken place has shown there is some(many?) on the sidelines whom are keen on more shares and obviously sellers are no longer abundant in these ranges, which leads me to wonder where the next supply zone range will be. I can say for certain that EMV's blue sky potential leaves it in a very select few stocks on the ASX whom I believe will perform well regardless of the macro economic conditions.
ASX:EMVLong
by Sto
EMV Failed C&H and possible bottom found. The past several sessions have seen significant fear based selling as the C&H formation failed its handle. Unfortunate timing for the continuation pattern to be affected by the macro economic conditions. I would suspect that some of the supply that made it's way into the ask was from the 74c capital raise that took place late last year. The bottom may have been found last session as we saw a green hammer on the daily with some bottom pickers licking their lips as the price dipped below the 66.5 support line. A great entry or top up for whomever managed to soak that supply. Today's session should indicated whether much of the fearful sellers have left the building and whether they may regret or revel in their decision to drastically dump their holdings.
ASX:EMVLong
by Sto
EMV Cup and Jandal Formation EMV has continued to impress with a tight capital structure and overwhelming demand. Capital Raise loose stock has been mostly absorbed in its pull back from $0.99 back down to $0.66. Once supply dwindled it was quite clear the bulls are fully in charge of the EMV trend. A C&H formation with a cup spread of 33.5c and what appears to be handle forming the last weekly session, although proper confirmation is still required this could indicated a continuation pattern with a target of $1.27. With material news nearing as EMVision continues pushing forward through its Pilot Clinical trial, the price action could coincide well with the expected news flow. Additionally the potential for a Research Grant through EMV's partner 'Australian Stroke Alliance' in the event it was successful could see a significant rerate and possibly fiscally pave the way for all future trial expenses. (I stress that this is not a certainty, but I am optimistic of EMV's chances.) EMV is an easy hold for me, with a 2-3 year vision in my trading plan. For those unfamiliar with the story this is a great listen. player.whooshkaa.com
ASX:EMVLong
by Sto
Emvision Incredibly tight longEmvision was out of the gates with an incredibly tight capital structure. Mkt cap $22.45M Ordinary fully paid shares 57,578,750 Options exercisable at $0.35 each 7,500,000 expiring on 31 Dec 2021 Performance Rights 6,000,000 $emv showed strength from day naught, and proceeded to demonstrate significant demand for the miniscule free float. A brief forced pull back has been caught at the 38c range and met with sideways motion soaking. Fundamentally one of the highest conviction stocks I've had the privilege of owning and technically ripe for a run.
ASX:EMVLong
by Sto